Durect DRRX 深 滬
等待開盤 08-05 09:30:00 美东时间
1.86
+0.025
+1.36%
華盛通- 最 高1.88
- 今 開1.84
- 成交量 78.55万股
- 最 低 1.82
- 昨 收 1.835
- 總市值 5773.92万
- 52周最高 2.64
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.4801
- 委 比 92.14%
- 總股本 3104.26万
- 歷史最高 39.49
- 量 比 0.07
- 振 幅 3.27%
- 歷史最低 0.4703
- 每 手 1
- 風險率 0.33%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NSC, SNV, DRRX, PNFP on Behalf of Shareholders
NEW YORK, July 31, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
08-01 08:57
Reported Earlier: Bausch Health To Acquire DURECT And Its FDA Breakthrough Epigenetic Modulator Larsucosterol For Alcoholic Hepatitis In $63M Deal Plus Milestones
DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy DesignationPotential to be the first FDA-approved therapeutic option for the treatment of patients with alcoholic
07-29 21:56
Durect Merges with Bausch Health for $1.75/Share
Durect ( ($DRRX) ) just unveiled an update. On July 28, 2025, DURECT Corporatio...
07-29 19:56
Durect Receives Nasdaq Delisting Notice Extension
Durect ( ($DRRX) ) has issued an update. DURECT Corporation received a notice f...
07-12 05:02
Analysts Offer Insights on Healthcare Companies: I-MAB (IMAB) and Durect (DRRX)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
05-18 01:40
Durect Q1 EPS $(0.13) Misses $(0.12) Estimate, Sales $321.00K Beat $291.67K Estimate
Durect (NASDAQ:DRRX) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.12) by 8.33 percent. This is a 48 percent increase over losses of $(0.25) per share from the same
05-14 04:23
Oppenheimer Sticks to Its Buy Rating for Durect (DRRX)
Oppenheimer analyst Francois Brisebois reiterated a Buy rating on Durect (DRRX ...
03-30 16:15
HC Wainwright & Co. Reiterates Neutral on Durectto Neutral
HC Wainwright & Co. analyst Ed Arce reiterates Durect (NASDAQ:DRRX) from Neutral to Neutral.
03-28 01:26
Durect Q4 2024 GAAP EPS $0.24 Beats $(0.02) Estimate, Sales $500.000K Miss $6.907M Estimate
Durect (NASDAQ:DRRX) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $(0.02) by 1300 percent. This is a 340 percent increase over losses of $(0.10) per share from the same
03-27 04:11
Earnings Scheduled For March 26, 2025
Companies Reporting Before The Bell • Allurion Technologies (NYSE:ALUR) is esti...
03-26 16:32
